| Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial YPM Goekoop‐Ruiterman, JK de Vries‐Bouwstra, CF Allaart, ... Arthritis & Rheumatism 52 (11), 3381-3390, 2005 | 2028 | 2005 |
| Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial YPM Goekoop-Ruiterman, JK de Vries-Bouwstra, CF Allaart, D van Zeben, ... Annals of internal medicine 146 (6), 406-415, 2007 | 671 | 2007 |
| Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial D Khanna, CJF Lin, DE Furst, J Goldin, G Kim, M Kuwana, Y Allanore, ... The Lancet Respiratory Medicine 8 (10), 963-974, 2020 | 443 | 2020 |
| Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single‐nucleotide polymorphisms in genes coding for folate pathway enzymes JAM Wessels, JK de Vries‐Bouwstra, BT Heijmans, PE Slagboom, ... Arthritis & Rheumatism 54 (4), 1087-1095, 2006 | 296 | 2006 |
| Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis M Güler-Yüksel, CF Allaart, YPM Goekoop-Ruiterman, ... Annals of the rheumatic diseases 68 (3), 330-336, 2009 | 287* | 2009 |
| A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc … K Visser, YPM Goekoop-Ruiterman, JK de Vries-Bouwstra, HK Ronday, ... Annals of the rheumatic diseases 69 (7), 1333-1337, 2010 | 278 | 2010 |
| Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis SM Van Der Kooij, YPM Goekoop-Ruiterman, JK De Vries-Bouwstra, ... Annals of the rheumatic diseases 68 (6), 914-921, 2009 | 259 | 2009 |
| DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis YPM Goekoop-Ruiterman, JK de Vries-Bouwstra, PJSM Kerstens, ... Annals of the rheumatic diseases 69 (01), 65-69, 2010 | 188 | 2010 |
| Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent‐onset rheumatoid arthritis JAM Wessels, WM Kooloos, RD Jonge, JK De Vries‐Bouwstra, CF Allaart, ... Arthritis & rheumatism 54 (9), 2830-2839, 2006 | 175 | 2006 |
| Fine specificity of the anti–citrullinated protein antibody response is influenced by the shared epitope alleles KN Verpoort, K Cheung, A Ioan‐Facsinay, AHM van der Helm‐van Mil, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2007 | 173 | 2007 |
| Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis SM van der Kooij, S le Cessie, YPM Goekoop-Ruiterman, ... Annals of the rheumatic diseases 68 (7), 1153-1158, 2009 | 171 | 2009 |
| Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis AE Van der Bijl, YPM Goekoop‐Ruiterman, JK de Vries‐Bouwstra, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2007 | 168 | 2007 |
| Progression of joint damage in early rheumatoid arthritis: association with HLA–DRB1, rheumatoid factor, and anti–citrullinated protein antibodies in relation to different … JK De Vries‐Bouwstra, YPM Goekoop‐Ruiterman, KN Verpoort, ... Arthritis & Rheumatism 58 (5), 1293-1298, 2008 | 166 | 2008 |
| Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study. CF Allaart, YP Goekoop-Ruiterman, JK de Vries-Bouwstra, FC Breedveld, ... Clinical and experimental rheumatology 24 (6 Suppl 43), S-77, 2006 | 158 | 2006 |
| Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow … D Farge, RK Burt, MC Oliveira, E Mousseaux, M Rovira, Z Marjanovic, ... Bone Marrow Transplantation 52 (11), 1495-1503, 2017 | 129 | 2017 |
| Cost‐utility analysis of treatment strategies in patients with recent‐onset rheumatoid arthritis WB Van den Hout, YPM Goekoop‐Ruiterman, CF Allaart, ... Arthritis Care & Research 61 (3), 291-299, 2009 | 125 | 2009 |
| Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score SM van der Kooij, JK de Vries-Bouwstra, YPM Goekoop-Ruiterman, ... Annals of the Rheumatic Diseases 66 (10), 1356-1362, 2007 | 124 | 2007 |
| Systemic sclerosis: state of the art on clinical practice guidelines V Smith, CA Scirè, R Talarico, P Airo, T Alexander, Y Allanore, C Bruni, ... RMD open 4 (Suppl 1), e000782, 2019 | 123 | 2019 |
| GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways E López-Isac, M Acosta-Herrera, M Kerick, S Assassi, AT Satpathy, ... Nature communications 10 (1), 4955, 2019 | 119 | 2019 |
| Bone mineral density in patients with recently diagnosed, active rheumatoid arthritis M Güler-Yüksel, J Bijsterbosch, YPM Goekoop-Ruiterman, FC Breedveld, ... Annals of the rheumatic diseases 66 (11), 1508-1512, 2007 | 112 | 2007 |
